ADC Therapeutics SA

$1.070
USD
Last updated on --.
24h volume7.20M
24h highest1.3750 USD
24h lowest1.0190 USD
24h Price movement+3.88%

ADCT recent prices

24 Hours
+3.88%+$0.04
30 days
-69.43%-$2.430
60 days
-71.31%-$2.660
90 days
-74.70%-$3.160

Key data

Previous close1.0300 USD
Market cap131.01M USD
Volume7.20M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.0800 USD
Net income (FY)-136.99M USD
Revenue (FY)79.18M USD
Last report dateMay 4, 2026

About ADC Therapeutics SA

PHARMACEUTICAL PREPARATIONS
HeadquartersEPALINGES
Employees (FY)193.00
Revenue per employee (FY)410.23K USD
Net income per employee (FY)-709.79K USD
Listed onNew York Stock Exchange
Official website

ADCT conversion tables

ADCTADCT
USDUSD
0.5 ADCT0.535 USD
1 ADCT1.070 USD
5 ADCT5.350 USD
10 ADCT10.7 USD
USDUSD
ADCTADCT
0.5 USD0.46729 ADCT
1 USD0.93458 ADCT
5 USD4.672 ADCT
10 USD9.345 ADCT

FAQ

ADCT is trading at $1.070, +3.88% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ADCT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ADCT is currently trading at $1.070, +3.88% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ADCT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ADCT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ADCT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ADCT's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
ADC Therapeutics SA's market cap is currently 131.01M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume7.20M
24h highest1.3750 USD
24h lowest1.0190 USD
24h Price movement+3.88%
ADCTADCT
USDUSD
Start trade with ADCT Perpetual